University of Aberdeen Recruits Lung Disease Patients for COPD Study
coughing The University of Aberdeen and Aberdeen Royal Infirmary in Scotland is recruiting patients suffering from lung diseases to enroll in a wide-ranging study in the United Kingdom designed to evaluate if an old and a new drug can work together in ...
Lung Disease News - Thu, 30 Oct 2014 14:56

FDA Approves First 2 Drugs for Treatment of a Fatal Lung Disease
The first two drugs that can slow the progression of a fatal lung disease won approval from the Food and Drug Administration on Wednesday, a decision that could open a new era for patients but also a new chapter in the controversy over high drug prices.
New York Times - Wed, 15 Oct 2014 17:52

FDA Approves Two Drugs to Treat Deadly Lung Disease
Wall Street Journal - Wed, 15 Oct 2014 14:01

CORRECTION - Two FDA Approvals on Same Day Renew Hope for Pulmonary ...
GlobeNewswire (press release) - Thu, 16 Oct 2014 14:22

Boehringer Ingelheim's OFEV™ (nintedanib*) approved by the FDA for the ...
Business Wire (press release) - Thu, 16 Oct 2014 02:11

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for ... - Wed, 15 Oct 2014 20:33

FDA Approves Esbriet® (pirfenidone) for the Treatment of Idiopathic Pulmonary ... (press release) - Wed, 15 Oct 2014 13:37

PH, CF & Other Lung Disease Research To Benefit from Cutting-Edge Lung ...
georgeosborne The U.K.'s Chancellor of the Exchequer, George Osborne, has announced that the University of Sheffield will be awarded £7.5 million to expand development of its world-leading clinical lung imaging research — technology that may lead to ...
Pulmonary Hypertension News - Mon, 27 Oct 2014 13:35

Lung disease patients needed for new £2 million treatment study
Researchers from the University of East Anglia (UEA) and Norfolk and Norwich University Hospital (NNUH) are looking for people with lung diseases to help with a £2 million study. They hope to find out whether using an old drug can help a relatively new ... - Tue, 28 Oct 2014 01:37

Volunteers needed for £2m Norfolk study into lung disease
Norfolk Eastern Daily Press - Tue, 28 Oct 2014 02:11

FDA Approves Boehringer Ingelheim's Drug for Lung Disease
Pirfenidone idiopathic pulmonary fibrosis (IPF) drug molecule.Boehringer Ingelheim Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) approved OFEV (nintedanib) capsules for oral use for the treatment of idiopathic ...
Drug Discovery & Development - Thu, 16 Oct 2014 10:55

FDA Approves OFEV for the Treatment of Idiopathic Pulmonary Fibrosis
Pharmaceutical Technology Magazine - Fri, 17 Oct 2014 09:11

COPD Patients Found to Benefit From Non-Invasive Open Ventilation System
Ventilation System and COPD SCIO Health Analytics recently presented promising results for the treatment of chronic obstructive pulmonary disease (COPD). Their results showed that using a non-invasive open ventilation system in patients with severe ...
Lung Disease News - Wed, 29 Oct 2014 06:05

Endemic lung infection compromises lung cancer diagnosis
The accuracy of lung cancer diagnosis using 18F-fluorodeoxyglucose–positron emission tomography (FDG–PET) may be compromised in areas with endemic infectious lung diseases, research suggests. Previous studies in areas with endemic lung infections ... - Thu, 30 Oct 2014 14:11

Researchers Develop Novel Gene/Cell Therapy Approach for Lung Disease
CINCINNATI, Oct. 1, 2014 /PRNewswire-USNewswire/ -- Researchers developed a new type of cell transplantation to treat mice mimicking a rare lung disease that one day could be used to treat this and other human lung diseases caused by dysfunctional ...
Virtual Press Office (press release) - Wed, 01 Oct 2014 10:03

1  2  3  4  5  6  7  8    ->

We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014